These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11715764)

  • 1. Disease registries for biologic and chemical terrorism.
    Hertzberg J
    Manag Care Interface; 2001 Nov; 14(11):58-9. PubMed ID: 11715764
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioterrorism watch. Signs and symptoms of chemical exposures.
    Hosp Peer Rev; 2002 Feb; 27(2):suppl 3. PubMed ID: 11924071
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of the early aberration reporting system (EARS) for detection of bioterrorism agent attacks.
    Hutwagner L; Barson JV
    Aviat Space Environ Med; 2005 Oct; 76(10):1001-2. PubMed ID: 16235888
    [No Abstract]   [Full Text] [Related]  

  • 4. Environmental health. National tracking plan picks up speed.
    Kaiser J
    Science; 2002 Apr; 296(5567):452-3. PubMed ID: 11964453
    [No Abstract]   [Full Text] [Related]  

  • 5. Arming labs with biopreparedness tools.
    Harms R
    Health Manag Technol; 2005 Dec; 26(12):16, 18-20. PubMed ID: 16381116
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical and biological warfare: improvisational agents.
    Stewart CE
    Emerg Med Serv; 2002 May; 31(5):88-90. PubMed ID: 12033057
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for protecting human health against potential adverse effects of long-term exposure to low doses of chemical warfare agents.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Feb; 37(5):72-4, 79. PubMed ID: 2828907
    [No Abstract]   [Full Text] [Related]  

  • 8. Counterterrorism planning using the Hazardous Substances Events Surveillance system.
    Manassaram DM; Orr MF; Kaye WE
    Disaster Manag Response; 2003; 1(2):35-40. PubMed ID: 12704318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomic laboratory and forensic aspects of biological threat agents.
    Marty AM
    Clin Lab Med; 2006 Jun; 26(2):515-40, x-xi. PubMed ID: 16815464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metropolitan Atlanta Congenital Defects Program surveillance data, 1988-1991.
    Teratology; 1993 Dec; 48(6):695-709. PubMed ID: 8115977
    [No Abstract]   [Full Text] [Related]  

  • 11. Responding to and managing casualties: detection, personal protection, and decontamination.
    Lepler L; Lucci E
    Respir Care Clin N Am; 2004 Mar; 10(1):9-21. PubMed ID: 15062224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioterrorism web site resources for infectious disease clinicians and epidemiologists.
    Ferguson NE; Steele L; Crawford CY; Huebner NL; Fonseka JC; Bonander JC; Kuehnert MJ
    Clin Infect Dis; 2003 Jun; 36(11):1458-73. PubMed ID: 12766842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of chemical biological terrorist events for children and pregnant women.
    Teran-Maciver M; Larson K
    MCN Am J Matern Child Nurs; 2008; 33(4):224-32; quiz 233-4. PubMed ID: 18664903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency department sentinel surveillance for emerging infectious diseases.
    Moran GJ; Kyriacou DN; Newdow MA; Talan DA
    Ann Emerg Med; 1995 Sep; 26(3):351-4. PubMed ID: 7661427
    [No Abstract]   [Full Text] [Related]  

  • 15. ATSDR fact sheets on hazardous substances. Agency for Toxic Substances and Disease Registry.
    Public Health Rep; 2001; 116(3):271. PubMed ID: 12269227
    [No Abstract]   [Full Text] [Related]  

  • 16. Early warning.
    Nat Med; 2002 Nov; 8(11):1183. PubMed ID: 12411924
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparing for bioterrorism.
    Occup Health Saf; 2002 Jul; 71(7):96-8. PubMed ID: 12162060
    [No Abstract]   [Full Text] [Related]  

  • 18. The registry and surveillance in hemoglobinopathies: improving the lives of individuals with hemoglobinopathies.
    Hoots WK
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S510-1. PubMed ID: 20331951
    [No Abstract]   [Full Text] [Related]  

  • 19. Our first line of defense against bioterrorism part 2.
    Simpson RL
    Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intentional use of biological and chemical agents: risks and recommendations.
    Roca A; Crape B; Chase G; Loyola E; Castillo-Salgado C
    Epidemiol Bull; 2001 Sep; 22(3):1-3. PubMed ID: 11797232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.